Because this situation is confusing for GPs who are the first line of treatment and advice for patients, the Urological Society of Australia and New Zealand is developing guidelines to assist GPs and their patients.
The guidelines are being developed in conjunction with key groups such as the Prostate Cancer Foundation of Australia, Cancer Australia, the Royal Australian College of Pathologists, the Royal Australian College of General Practitioners and the National Health and Medical Research Council.
The guidelines will consider the stratification of risk levels for individuals, and offer explanations regarding differentiation of low, versus high risk, cancer.
“We feel this is an important point to explain why some cancers can be safely observed as opposed to those that require therapy. We believe a more detailed explanation of active surveillance is necessary highlighting who may benefit from early surgery and who may not,” said Professor Mark Frydenberg of the Urological Society.
‘Movember’ draws to a close on Friday. It’s not too late to sponsor someone who’s growing a moustache to help raise awareness and funds – or go direct to the ‘Movember’ website and make a contribution to the programs of beyondblue, the Prostate Cancer Foundation of Australia and the ‘Movember’ Foundation.
__small.png)
